Introduction
============

To date, HIV testing remains the cornerstone of HIV prevention and care. Approximately 15% of 1.2 million individuals living with HIV in the United States are unaware of their infection \[[@ref1],[@ref2]\], and some estimates suggest that these individuals account for almost one-third of all sexual transmissions in the United States \[[@ref3]\]. HIV-positive individuals can be linked to HIV care and antiretroviral therapy (ART), which can improve individual health outcomes and decrease the likelihood of transmission \[[@ref4]\]. In contrast, HIV-negative individuals can be linked to HIV prevention strategies, such as pre-exposure prophylaxis (PrEP) \[[@ref5]\]. In the United States, men who have sex with men (MSM) constitute a high-risk group for acquiring HIV, and CDC recommends that MSM should undergo tests for HIV, at least, annually \[[@ref6]\]. Despite this recommendation, only 56% of US MSM were reported to have undergone the tests in 2015 \[[@ref7]\]. The low rate of testing has hindered linking the requisite number of MSM to treatment and prevention of HIV to bring down the rate of new infections below the effective reproductive number. Consequently, HIV diagnoses among young MSM, especially young black MSM in the United States, has been increasing \[[@ref8]\].

In 2012, the United States Food and Drug Administration approved the first HIV self-test (HIVST), the OraQuick In-Home HIV Test (OraQuick; OraSure Technologies, Inc; Bethlehem, PA, USA). HIVSTs are the tests that can be entirely performed by the person undergoing the test for HIV, from specimen collection to reading and interpreting test results. One rationale for OraQuick's approval was that the availability of self-testing---a testing modality that provides convenience, privacy, and anonymity---might decrease the number of people living with HIV who remain unaware of their HIV status \[[@ref9]\]. HIVST promises to increase the frequency and coverage of testing in several ways. Self-testing offers a way to reach not only people who are in need of HIV testing but also those who are either not linked to medical care or hesitant to attend testing in community-based settings \[[@ref10]\]. In addition, HIVST could provide opportunities to supplement current, clinic-based testing to elevate the testing frequency for MSM. However, HIVST using oral fluids has an extended window period, during which individuals recently infected with HIV might test falsely negative \[[@ref11]\], which might incorrectly reassure people with recently acquired HIV infection; furthermore, such individuals are highly infectious \[[@ref12]\]. Such people might delay treatment initiation and expose their uninfected partners to HIV. Moreover, they might postpone their next test, further delaying both diagnosis and treatment. Furthermore, people who test positive using HIVST might not be linked to care as frequently as those who test in more traditional settings, such as clinics.

Typically, HIVSTs have been found to be highly acceptable among MSM \[[@ref13]\], and studies have established the feasibility and acceptability of various strategies for distributing HIVST kits among MSM \[[@ref14]\], including social and sexual networks \[[@ref15],[@ref16]\], geosocial networking apps \[[@ref17]\], bathhouses \[[@ref18]\], vending machines \[[@ref19]\], vouchers \[[@ref20]\], mass distribution at LGBTQ--focused events (lesbian, gay, bisexual, transgender, and queer, LGBTQ) \[[@ref21]\], or Web-based strategies \[[@ref22]\]. However, the use of HIVSTs in the general MSM population or outside of research studies remains partially investigated. Studies among Australian and Spanish MSM before local regulatory approval and among MSM receiving partner services for newly diagnosed HIV in New York City reported extremely low histories of prior HIVST use (\<2.5%) \[[@ref23]-[@ref25]\]. Conversely, surveillance data from King County, WA, suggested that approximately 20% of MSM had used an HIVST by 2015 \[[@ref21]\]. Empirical patterns of HIVST use and the extent to which men will supplement or replace clinic-based testing with HIVST will be elucidated in future studies. The objective of developing our present model was to investigate how different patterns of use might affect the HIV incidence and, thus, inform how to promote self-testing.

Our research groups have conducted prior modeling work in several areas related to HIV testing. Katz et al \[[@ref26]\] developed a deterministic, continuous-time model of HIV transmission dynamics, suggesting that any replacement of clinic-based tests capable of detecting recent HIV infection with self-testing leads to an increased HIV prevalence among Seattle MSM, irrespective of the impact of self-tests on testing frequency. However, one limitation of this model was that it investigated replacing clinic-based tests only and did not consider other ways in which MSM may use HIVST \[[@ref27]\]. Furthermore, there was lack of stochasticity in outcomes, infeasibility of parameterizing certain network structures, and exponential complexity with the linear addition of parameters. It would not be feasible to represent the level of heterogeneity in testing qualities, profiles of testers, and testing scenarios in a compartmental model, nor could the model account for specific sex acts and subsequent seroadaptive behavior based on the combination of test results. Khanna et al \[[@ref28]\] reported the potential benefits of individualized HIV testing programs for decreasing HIV transmissions among MSM, and Delaney et al \[[@ref29]\] used agent-based models to evaluate the potential value of focusing testing programs on MSM who had never been tested before. Both studies highlighted the potential benefits of HIV testing programs at the individual level to decrease the HIV prevalence among MSM; however, these agent-based models did not explicitly account for the use of HIVSTs or nuanced HIV testing behaviors.

Modeling offers an opportunity to process the available information from studies of self-testing, inform the design of self-testing interventions, compare how self-testing could be most effectively used in different epidemiological settings, and estimate the likely impact of scaling self-testing programs for MSM. Thus, we aimed to develop an agent-based model to investigate the potential impact of these tests on the HIV epidemic among MSM from two different epidemic settings in the United States---Atlanta, GA, and Seattle, WA. Approaches like ours are efficient, cost-effective, and complementary to community-level randomized controlled trials for assessing interventions like self-testing, especially in the setting of broad availability of self-tests and diverse programs, including self-tests being provided by health programs. Briefly, we aimed to develop a network-based mathematical model of HIV transmission dynamics in susceptible populations of MSM in Atlanta and Seattle.

Methods
=======

Study Design
------------

We adapted and extended a previously published, dynamic, stochastic network model of HIV transmission dynamics, which was originally designed to elucidate racial disparities in HIV prevalence among MSM in Atlanta \[[@ref30]\]. The original model comprised key aspects of HIV transmission dynamics among MSM, including the occurrence of condomless anal intercourse (CAI) and related HIV transmission probabilities, sexual partnership characteristics (eg, main or casual partnerships), HIV testing frequency, and HIV care seeking. In the original model, MSM possessed fixed (eg, race and circumcision status) and dynamic (eg, age and infection status) attributes. In addition, HIV-infected men possessed additional dynamic attributes (eg, diagnosis status, treatment status, infection stage, and plasma HIV RNA level). Consistent with prior studies \[[@ref31],[@ref32]\], sexual contact networks used separable temporal exponential random graph models (STERGMs) \[[@ref33]\], a flexible statistical framework for simulating partnership formation and dissolution across networks \[[@ref34]\], facilitating one to match data on the complex cross-sectional network structure, as well as reported relational durations. We implemented STERGMs in the R package suite *statnet* \[[@ref35]\] and *EpiModel* \[[@ref36]\]. The specific parameters for the sexual behavior developed by the domain and city are presented in Appendix Table A1.

HIV Transmission and Progression
--------------------------------

In the model, sexual contacts occurred on three networks, each of which shared the same set of nodes (people) but represented a different relationship type: main partners, casual partners, and one-time partners. Partnership formation depended on the following four predictors: partnership types (main, casual, or one-time partners), degree distribution (number of ongoing partners for each individual), age homophily (partners with similar age), and sexual role segregation (only those men who engaged in receptive anal sex could pair with men who engaged in exclusively insertive anal sex and vice versa). There was a constant relationship dissolution hazard for main and casual partnerships based on the median duration of each type ([Multimedia Appendix 1](#app1){ref-type="supplementary-material"}, Table A1).

HIV progression followed both a natural trajectory of disease, in the absence of ART, and an ART-mediated trajectory \[[@ref37]\]. In the absence of ART, HIV viral loads progressed in three stages: peak viremia during acute HIV infection (21 days); a set point viral load during the clinical latency (42 days); and a subsequent increase, resulting in AIDS and disease-induced mortality (728 days) \[[@ref38]\]. In serodiscordant pairs, HIV transmission probabilities included those mediated by the viral load of the positive partner \[[@ref39]\], condom use \[[@ref40]\], the presence of the CCR5-Δ32 genetic allele \[[@ref41],[@ref42]\], receptive versus insertive sexual position of the HIV-negative partner \[[@ref31]\], and the circumcision status of an insertive HIV-negative partner \[[@ref43]\]. After infection, men were assigned to three clinical care trajectories: those who never initiate treatment; those who initiate treatment and become partially suppressed; and those who initiate treatment and become entirely suppressed. The three trajectories exhibited different rates of infectiousness, HIV diagnosis, ART initiation, HIV viral suppression, and progression to AIDS and death to match empirical estimates of the prevalence of these states \[[@ref44]\]. Furthermore, ART decreased the viral load and its associated transmission risk \[[@ref4]\] and extended the life span \[[@ref45]\].

HIV Pre-Exposure Prophylaxis
----------------------------

We included PrEP use and adherence as additional features of the model. At any given time, 23.4% of HIV-negative MSM in the Seattle model and 11% of HIV-negative men in the Atlanta model were on PrEP according to Darcy Rao (oral communication, May 2017). If the proportion of HIV-negative MSM on PrEP decreased below the threshold coverage because of discontinuation or seroconversion, newly tested HIV-negative MSM were allowed to start PrEP. In addition, MSM on PrEP received a diagnostic HIV test at regular intervals (3 months). In fact, MSM who started PrEP were assigned a fixed adherence profile that reflected an average weekly dosage using data from the US PrEP Demo Project \[[@ref46]\] weighted by race or ethnicity using methods from Jenness et al \[[@ref32]\], which investigated the impact of the implementation of the US Centers for Disease Control and Prevention's PrEP guidelines on the national HIV epidemic among MSM. For the Atlanta model, we assigned 21.1% of men as nonadherent (0 doses), 7.0% taking \<2 doses/week, 10.0% taking 2-3 doses/week, and 61.9% taking ≥4 doses/week; for the Seattle model, we assigned 14.4% as nonadherent, 4.1% taking \<2 doses/week, 5.3% taking 2-3 doses/week, and 76.2% taking ≥4 doses/week \[[@ref32]\]. The probability of HIV acquisition per sex act was decreased according to the level of adherence. Little evidence for risk behavior changes among MSM while on PrEP was found in studies predating the development of this model \[[@ref46]-[@ref49]\]; thus, we focused on the PrEP coverage and adherence and did not model such behavior changes.

HIV Testing: Clinic and Self-Testing
------------------------------------

To investigate the possible impacts of HIV self-testing strategies on HIV epidemic dynamics in future models, we added more complex parameters describing clinic-based HIV testing behaviors to the original model to create a new baseline model. As existing patterns of the testing behavior vary among MSM, we conceptualized this baseline model with four tester types \[[@ref50]\] ([Table 1](#table1){ref-type="table"}): (1) those who do not test in any setting ("never testers"); (2) those who test for HIV, but without a regular testing interval and without considering sexual episodes (eg, testing outreach at Pride festivals or when seeking medical care for a non-HIV or STD-related reason; "opportunistic-only testers"); (3) those who test for HIV regularly, irrespective of sexual behaviors ("regular testers"); and (4) those who test for HIV in response to a specific sexual episode (eg, CAI with a partner of unknown HIV serostatus; "risk-based testers"). Both regular and risk-based testers could also have an opportunity to become opportunistic testers and test outside of their regular testing interval or in the absence of a specific sexual episode, respectively, when opportunities were available. In addition, many public health agencies recommend different testing frequencies for MSM at higher versus lower risk for HIV acquisition \[[@ref51]-[@ref54]\], and evidence suggests that on an average, MSM at higher risk test more frequently \[[@ref55]-[@ref60]\]. Consequently, we stratified regular testers into high vs low anal intercourse (AI) frequency groups to allow for differential testing frequencies by risk.

The four categories of HIV tester types ([Table 1](#table1){ref-type="table"}) in the baseline model provide a framework to investigate the efficacy of different HIV self-testing scenarios for both Atlanta and Seattle. In the next stage of this research, we will implement two different self-testing intervention strategies: replacement testing and supplementary testing ([Table 2](#table2){ref-type="table"}). In the replacement testing scenarios, we will evaluate the proportion of HIV infections averted when HIVSTs replace clinic-based opportunistic tests, regular tests, and risk-based tests, respectively and simultaneously. In addition, we will assess the impact of replacing 25% and 50% of clinic-based tests with HIVSTs, assuming a 90-day window period (duration between when a person might have been exposed to HIV and when a test can give an accurate result) for self-tests \[[@ref61]\].

We will also model the proportion of HIV infections averted when self-tests supplement clinic-based tests. In these scenarios, never testers and opportunistic-only testers take one or two supplementary HIVSTs randomly each year. Regular testers can supplement clinic-based tests with HIVSTs in two ways.

###### 

HIV testing typology for the baseline model (clinic test only) of HIV transmission dynamics among men who have sex with men in Seattle and Atlanta.

  Tester type                  Baseline testing behavior                                                                                                                                                                           Opportunistic testing behavior
  ---------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------
  Never testers                None                                                                                                                                                                                                None
  Opportunistic-only testers   None                                                                                                                                                                                                Likelihood of testing when presented with an opportunity to test (varies by the tester type)
  Regular testers              Test interval varies by HIV risk category (defined by high vs low AI^a^ frequency)                                                                                                                  
  Risk-based testers           Testing likelihood and time to test varies by three types of events: (1) CAI^b^ in non‐main partnership, (2) CAI within known serodiscordant partnership, and (3) Acquisition of new main partner   
                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                   

^a^AI: anal intercourse.

^b^CAI: condomless anal intercourse.

###### 

Scenarios for modeling uptake of HIV self-testing among men who have sex with men: replacement versus supplementary testing (to be compared with the baseline model).

  Tester type                  Replacement scenarios            Supplementation scenarios
  ---------------------------- -------------------------------- ----------------------------------------------------------------------------------------------------
  Never testers                N/A^a^                           1 test per year2 tests per year
  Opportunistic-only testers   25% replacement50% replacement   1 additional test per year2 additional tests per year
  Risk-based testers           25% replacement50% replacement   10% additional probability of testing after risk event20% additional probability
  Regular testers              25% replacement50% replacement   1 additional test per year at random timeDecrease the intertest interval by adding 1 test per year

^a^N/A: not applicable.

First, they can supplement clinic tests with one additional HIVST randomly during a year. Second, they can test more frequently (ie, shorter intertest interval) using both clinic tests and self-tests. For example, if a regular tester tests three times a year in a clinic, his intertest interval would be 120 days; if he supplements this with one self-test per year, his intertest interval would be 90 days, and he would have a 25% chance that each test would be a self-test. Risk-based testers supplement their clinic-based tests by increasing the probability of risk-based tests by 10% and 20%. For example, if a risk tester has a 40% chance of taking a clinic-based test after a risk event and self-testing increases the probability of risk-based testing by 10%, his likelihood of testing becomes 50% with a 40% chance of taking a clinic-based test and a 10% chance of self-testing.

Results
=======

Data Parameterization
---------------------

We hypothesized that the impact of HIVST on MSM will differ in cities with different underlying patterns of HIV testing, access to HIV prevention and care, and epidemiological characteristics of MSM. King County (home to Seattle) is one of the first jurisdictions to reach the World Health Organization's 90-90-90 goals \[[@ref62]\] and has witnessed a rapid scale-up of PrEP \[[@ref63]\]. HIV prevalence among MSM in Seattle is estimated to be 11% according to Dr Susan Buskin (personal communication, October 2017), and the rate of new HIV diagnoses has been declining over the last decade \[[@ref64]\]. In contrast, the HIV prevalence among MSM in Atlanta is estimated to be much higher at 28% \[[@ref65]\], with fewer MSM aware of their HIV infection status \[[@ref66]\], exhibiting less access to PrEP and a more diverse population with significant disparities in HIV by race \[[@ref67]\]. The data sources for parameterizing our model for each city are presented in [Table 3](#table3){ref-type="table"}, with additional detail in the Appendix Table A1. As the original model was structured to assess racial differences in the incidence, where race-stratified estimates were available, we used those estimates to create race-weighted composite estimates for the overall population in each city. Both HIV testing and network-based behavioral data were collected in a prospective cohort study \[[@ref65]\] and an egocentric sexual network study \[[@ref68]\] of MSM in Atlanta and cross-sectional surveys of MSM in Seattle \[[@ref55],[@ref69]\].

We estimated parameters to characterize HIV testing behaviors in both Atlanta and Seattle, including the proportions of the four tester types ([Table 4](#table4){ref-type="table"}) and mean test intervals and test likelihood for opportunistic-only, regular, and risk-based testers ([Table 5](#table5){ref-type="table"}). Of note, these HIV testing parameters only apply to MSM who are not on PrEP (MSM on PrEP received a diagnostic HIV test at regular 3-month intervals). For Seattle, the proportions of the four tester types, the mean intervals between regular tests stratified by the frequency of AI, and the likelihood that opportunistic testers will seize a testing opportunity were estimated using data obtained from 361 HIV-negative and unknown-status MSM aged 18-39 years who participated in the Seattle Pride Survey \[[@ref63]\] in 2013 and 2014 and reported living in Washington State. The Pride Survey is an annual convenience sample of self-identified MSM enrolled from along the Seattle Pride Parade route to complete a self-administered survey to monitor HIV risk behaviors and the uptake of treatment and prevention interventions. The 2013 and 2014 surveys included the following question: "How many HIV tests did you have in the last two years?" To calculate the mean interval in days between regular tests, we divided 2 years (730.5 days) by the mean number of HIV tests reported in the last 2 years among the participants reporting their last test as a "routine test," stratified by the number of AI partners in the last year (0-2 vs 3+ partners). In addition, we calculated the likelihood that opportunistic-only testers will seize a testing opportunity by dividing the mean number of HIV tests reported in the last 2 years by the expected number of opportunities to test in a 2-year period (4 opportunities: 2 each year, based on expert opinion) among participants who reported the reason for their last test as something other than risk-based or routine.

For MSM in Atlanta, the proportions of the four tester types were estimated using data from the Man Project \[[@ref68]\] and InvolveMENt \[[@ref65]\]. The Man Project was a cross-sectional, chain-referral sexual network study among 314 MSM; however, InvolveMENt was a prospective cohort study among 803 black and white non-Hispanic MSM aged 18-39 years. Participants for both the studies completed self-administered computer-based questionnaires that assessed demographics as well as risk and prevention behaviors for both themselves and their most recent sex partners (up to the last 10 partners in the last 12 months for the Man Project and the last 5 partners in the previous 6 months for InvolveMENt). We evaluated the mean interval in days between regular tests using data from the PUMA Survey \[[@ref70]\], an internet-based survey of MSM in the United States conducted from November 30, 2010 to December 19, 2010 (*n*=1251). Men who reported regularly testing for HIV were asked how often they tested (in months). Then, we calculated the mean number of months between regular tests, but unlike for the parameters of MSM in Seattle, we were unable to stratify this interval by the number of AI partners. Furthermore, we calculated the likelihood that opportunistic-only testers seized an opportunity from data collected in the Annual American Men's Internet Survey of Behaviors of Men who have Sex with Men in the United States (AMIS) \[[@ref7],[@ref69],[@ref71]\]. AMIS is an annual cross-sectional behavioral survey of MSM in the United States in which participants complete a Web-based survey that includes questions in the following domains: demographics, sexual behavior, HIV testing history, drug and alcohol use, and HIV prevention services exposure. As with the Seattle data, the likelihood was calculated among participants who self-reported living in Georgia and reported testing for reasons other than risk or routine by dividing the mean number of HIV tests reported among them in the last 2 years by the expected number of opportunities in that period.

Where local data for parameterization were unavailable for both cities, we used estimates from national Web-based surveys conducted by research teams involving members of our group. The likelihood of seizing a testing opportunity among regular and risk-based testers was estimated by calculating the proportion of individuals who reported currently testing on a regular schedule and reported that their last test was in response to an opportunity using data from the Internet Ethics and Incentives Study \[[@ref7],[@ref37],[@ref69]\]. Specifically, to parameterize this model, we added questions to the 2016 cycle of AMIS \[[@ref7],[@ref37],[@ref69]\] to ascertain the likelihood of testing following a risk event and the time from the risk event to test. Respondents were asked whether they tested in response to each of the following events: the last time they had CAI with a nonmain partner, the last time they had CAI with a serodiscordant partner, and the last time they started a new relationship. In addition, we calculated the likelihood of testing following each event as the proportion of individuals who reported testing in response to such an event among those who reported the event. Subsequently, men who reported that they last tested in response to CAI with a nonmain partner, CAI with a serodiscordant partner, or starting a new relationship were asked how many weeks following the event they tested. The time from event to test was calculated as the mean number of weeks for each type of event separately.

Model Calibration
-----------------

Using the above parameters, we simulated the sexual, vital, and epidemiological dynamics of HIV transmission among 10,000 MSM for 50 years using Seattle- and Atlanta-specific parameterizations and, at equilibrium, reproduced the epidemiological and demographic outcomes observed in Seattle and Atlanta, respectively. In addition, we calibrated the baseline models by varying the rate of AI within partnerships to closely match the estimates of HIV prevalence that were 28% in Atlanta and 11% in Seattle among MSM ([Figure 1](#figure1){ref-type="fig"}). We used a multiplier of 1.5 in Atlanta and 3.45 in Seattle to adjust the AI rate, which resulted in simulated epidemics equilibrating at 27.24% (95% CI: 27.79-28.35) in Atlanta and 11.55% (95% CI: 11.36-11.73) in Seattle. To select the multiplier, we varied the AI multiplier by 0.01 within preselected ranges of 1.45-1.55 and 3.4-3.5 for Atlanta and Seattle, respectively. Then, we identified the value that resulted in an average equilibrium HIV prevalence (from 100 simulations for each value for 50 years each) closest to the target estimates.

The next steps in our research will be to introduce each self-test scenario into the simulated populations and project epidemic outcomes over a 10-year time horizon. We will further investigate how different test sensitivities and detection windows affect the impact of HIVST.

###### 

Data sources for parameterization of a model of HIV transmission dynamics among MSM in Atlanta, GA, and Seattle, WA.

  Parameters                                                                                            Atlanta Data Sources                                                                                               Seattle Data Sources
  ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------
  Testing and treatment                                                                                 InvolveMENt \[[@ref65],[@ref72]-[@ref74]\]                                                                         Medical Monitoring Project \[[@ref75],[@ref76]\], HIV Surveillance \[[@ref62],[@ref77]\]
  Tester type                                                                                           AMIS^a^ \[[@ref7],[@ref69],[@ref71]\], Man Project \[[@ref68]\], InvolveMENt \[[@ref65]\]                          Seattle Pride Survey \[[@ref63]\]
  Mean interval between tests among regular testers                                                     PUMA^b^ Survey \[[@ref70]\]                                                                                        Seattle Pride Survey \[[@ref63]\]
  Likelihood of seizing the testing opportunity for risk-based, regular, and opportunity-only testers   Internet Ethics and Incentives Study \[[@ref78]\], American Men\'s Internet Survey \[[@ref7],[@ref69],[@ref71]\]   Internet Ethics and Incentives Study \[[@ref78]\], Seattle Pride Survey \[[@ref63]\]
  Risk-based testing: the likelihood of testing after event and time from event to test                 American Men\'s Internet Survey \[[@ref7],[@ref69],[@ref71]\]                                                      American Men\'s Internet Survey \[[@ref7],[@ref69],[@ref71]\]
  Sexual behavior (ie, versatility, condom use, disclosure); sexual network attributes                  Man Project \[[@ref68]\], InvolveMENt \[[@ref65]\]                                                                 Mobile Study (S. Cassels, Personal Communication, November 2017)
  Prevalence of circumcision                                                                            InvolveMENt \[[@ref65]\]                                                                                           National HIV Behavioral Surveillance \[[@ref66],[@ref79],[@ref80]\]
  PrEP coverage                                                                                         PUMA Survey \[[@ref70]\]                                                                                           Washington HIV Prevention Project
  Expected coital frequency within partnerships                                                         PUMA Survey \[[@ref70]\]                                                                                           Washington HIV Prevention Project
  Racial or ethnic distribution of MSM for weighting parameters estimates                               Goodreau et al \[[@ref30]\]                                                                                        King County Population Estimates \[[@ref81]\]
  CCR5-Δ32 prevalence                                                                                   Marmor et al \[[@ref82]\]                                                                                          Zimmerman et al \[[@ref41]\] and Marmor et al \[[@ref82]\]

^a^AMIS: Annual American Men's Internet Survey of Behaviors of Men who have Sex with Men in the United States.

^b^PUMA: Prevention Umbrella for MSM in the Americas.

###### 

Estimated proportions of four tester types in Atlanta and Seattle.

  Tester type                  Atlanta   Seattle
  ---------------------------- --------- ---------
  Never testers                3.5%      2.5%
  Opportunistic-only testers   37.0%     13.8%
  Regular testers              44.0%     64.9%
  Risk-based testers           15.5%     18.8%

###### 

Mean test intervals and test likelihood for opportunistic-only, regular, and risk-based testers in both Atlanta and Seattle.

  -----------------------------------------------------------------------------------------------------------------------------------------
  Tester Type                      Atlanta                                                                          Seattle     
  -------------------------------- -------------------------------------------------------------------------------- ----------- -----------
  **Opportunistic-only testers**   \                                                                                \           

  \                                Interval between opportunities to take an opportunistic test                     183 days    183 days

  \                                Likelihood of seizing testing opportunity: Opportunistic-only testers            0.629       0.764

  **Regular testers**              \                                                                                \           

  \                                Interval between regular tests for high AI frequency group                       224 days    151 days

  \                                Interval between regular tests for low AI frequency group                        224 days    372 days

  \                                Likelihood of seizing testing opportunity: Regular tester                        0.095       0.095

  **Risk-based testers**           \                                                                                \           

  \                                Likelihood of testing after event: CAI in non-main partnership                   0.339       0.359

  \                                Likelihood of testing after event: CAI within known serodiscordant partnership   0.520       0.538

  \                                Likelihood of testing after event: Acquisition of new main partner               0.349       0.375

  \                                Time from event to test: CAI in non-main partnership                             39.2 days   39.2 days

  \                                Time from event to test: CAI within known serodiscordant partnership             43.4 days   43.4 days

  \                                Time from event to test: Acquisition of new main partner                         56.7 days   56.7 days

  \                                Likelihood of seizing testing opportunity: Risk-based tester                     0.095       0.095
  -----------------------------------------------------------------------------------------------------------------------------------------

![Simulated HIV prevalence plots to produce baseline epidemics for Atlanta, GA, and Seattle, WA, with 95% CIs (gray band). The actual HIV prevalence among the men who have sex with men population was 28% in Atlanta and 11% in Seattle.](publichealth_v4i2e58_fig1){#figure1}

Discussion
==========

This study adapted our previous dynamic, network-based epidemic model of HIV transmission dynamics \[[@ref30]\] and conceptualized and implemented a baseline model as a platform for investigating different HIVST intervention strategies at the individual level. These dynamic network models are ideal for investigating the effects of complex, interacting interventions along structured and evolving contact networks \[[@ref31]\]. Our primary improvement was adding four different types of testers to this model (never testers, opportunistic-only testers, regular testers, and risk-based testers) and deriving estimates of prevalence as well as patterns of testing behaviors for each tester type. It will enable us to better reflect the range of testing behaviors among MSM than other models, which usually assume that all men test in the same manner, and will enable us to assess the potential impact of targeting self-testing to specific types of testers. In addition, we estimated the parameters related to HIV behaviors among MSM in Atlanta and Seattle to compare the impact of different epidemic settings on HIVST intervention strategies. Our enhanced model will be used to examine self-testing intervention strategies to determine the most effective ways to promote HIVST for MSM in the United States. Furthermore, our models offer great promise to account for novel testing strategies and to inform public health approaches for the promotion of safe and effective HIV self-testing strategies in two divergent settings, Seattle and Atlanta.

As with all models, ours has several limitations. First, to match the observed HIV prevalence in Seattle and Atlanta, our models required calibration for one behavioral parameter, the frequency of AI within partnerships. Not all factors that contribute to the differential HIV transmission dynamics could be included in this model; thus, the variation in the frequency of AI within partnerships could also represent the variation in the processes not included in the model. For example, we adopted a simplistic approach to PrEP use in our model. PrEP indications, uptake, and use over time are complex behaviors, and individuals who initiate PrEP might be nonrandomly associated with certain tester types. However, we modeled PrEP use as a consistent coverage fraction and did not have detailed data to parameterize how PrEP use interacted with our newly parameterized testing categories. Our models were based on data collected from numerous data sources, rather than one comprehensive, representative source for each city, and in some cases, local data sources were unavailable; thus, we had to rely on national surveys that are unlikely to be representative of either city. Second, testing parameters relied primarily on self-reported behaviors. Thus, the findings from the model will be considered as hypothetical scenarios to illustrate how similar approaches to HIV testing, self-testing in particular, can affect HIV transmission dynamics in various ways in different epidemic settings. Furthermore, our model should not be used as a prediction tool to assess the trajectory of the epidemic for specific subpopulations. Finally, the testing categories are static in the model. Hence, further investigations are warranted to elucidate how individual testing behavior varies over the life span.

HIVST provides a new opportunity to reach out to people who are in need of HIV testing. Understanding how to maximize the potential of HIV self-testing---and limit its risks---in the current landscape of high-sensitivity and high-throughput HIV testing is important. However, evaluations of self-testing programs have been limited in that it is difficult to assess who might be using the kits, what the results of the tests are, and, thus, what impact the self-tests might have on the epidemic. We executed a new modeling project to focus on the potential roles of self-tests in increasing HIV testing and decreasing the HIV incidence among MSM and to develop a model that would facilitate the assessment of how local epidemic characteristics might affect the impact of self-testing programs. The objectives were attained by developing parallel models for Seattle and Atlanta, which are different in their epidemics among MSM regarding testing behaviors; access to HIV testing, prevention, and care; and demographic and epidemic characteristics \[[@ref83]\]. The finalization of this protocol will enable us to examine the population-level effects of HIVST; test different HIVST intervention strategies, such as replacement and supplementary testing, and mass and targeted distributions; and determine populations and settings where HIVST might have the greatest impact \[[@ref84]\]. Overall, this study represents one more step forward in unfolding the process of improving the realism of epidemic models, and parameterizing them using rich local data, to best determine the optimal strategies for promoting population health in different communities.
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The specific parameters for sexual behavior developed by domain and city.

AI

:   anal intercourse

ART

:   antiretroviral therapy

CAI

:   condomless anal intercourse

CDC

:   Centers for Disease Control and Prevention

HIVST

:   HIV self-test

MSM

:   men who have sex with men

PrEP

:   pre-exposure prophylaxis

PUMA

:   Prevention Umbrella for MSM in the Americas
